Delivery Order 75F40123D00001-75F40123F19008
Award Date 2/21/23
Potential Completion Date 8/13/23
Potential Value $38K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bothell, WA 98021, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award to Illumina, Inc., a biotechnology company specializing in genetic sequencing and genomic analysis technologies. The award, worth $205,330.37, is for the supply of Illumina reagent chemistry kits to the Food and Drug Administration (FDA), a civilian agency. The contract is a Delivery Order with a Firm Fixed Price pricing type, with a completion date of September 30, 2024. The contract does not have a set-aside designation, reflecting Illumina's specialized...
- This is a federal contract award to Illumina, Inc., a biotechnology company specializing in genetic sequencing and genomic analysis technologies. The contract, valued at $429,380.88, is for the provision of Illumina reagent chemistry kits to the Food and Drug Administration (FDA), a civilian agency. The contract is a delivery order with a firm fixed price pricing type and has an ultimate completion date of September 30, 2024. The contract is not set aside for any specific business category....
- This is a federal contract award to Illumina, Inc., a for-profit manufacturer of genetic sequencing and genomic analysis technologies, by the Food and Drug Administration (FDA), a civilian agency. The contract is for the delivery of Illumina Reagent Chemistry Kits and has a ceiling value of $53,280.48. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of March 31, 2025. This contract award is not associated with a set-aside designation....
- This is a federal contract award from the Food and Drug Administration (FDA) to Illumina, Inc., a biotechnology company specializing in genetic sequencing and genomic analysis technologies. The contract is for the procurement of ILLUMINA REAGENT CHEMISTRY KITS, with a ceiling value of $142,372.18 and a completion date of September 30, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation. Illumina, Inc. is the prime contractor for...
- This federal contract award to Illumina, Inc. is for the provision of ILLUMINA REAGENT CHEMISTRY KITS to the Food and Drug Administration (FDA), a civilian federal agency. The $23,563.22 Firm Fixed Price Delivery Order contract has an ultimate completion date of September 17, 2025. Illumina, a for-profit manufacturer of genomic sequencing technologies, has been awarded this direct contract without any set-aside designation, indicating the company's specialized capabilities. The award is not...
- This is a federal contract award to Illumina, Inc., a biotechnology company specializing in genetic sequencing and genomic analysis technologies. The contract, valued at $25,624.89, is for the provision of Illumina reagent chemistry kits to the Food and Drug Administration (FDA), a civilian agency. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of September 30, 2025. The contract was awarded on June 5, 2025 and does not have a...
- This is a federal contract award to Illumina, Inc., a biotechnology company specializing in genetic sequencing and genomic analysis technologies. The contract, valued at $219,167.07, is for the provision of Illumina reagent chemistry kits to the Food and Drug Administration (FDA), a civilian agency. The award is a delivery order contract with a firm fixed price, and the ultimate completion date is June 13, 2023. The contract does not have a set-aside designation. Illumina is a well-established...
- This is a firm fixed-price delivery order contract awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a leading biotechnology company specializing in genetic sequencing and genomic analysis technologies. The contract, valued at $51,133.42, is for the provision of Illumina's reagent chemistry kits, which are critical to scientific research, healthcare, and diagnostic applications across various domains. The contract has an ultimate completion date of August 31, 2028 and does not...
- This is a Firm Fixed Price Delivery Order contract awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a for-profit manufacturer of genetic sequencing technologies. The contract, valued at $39,010.14, is for the provision of Illumina's reagent chemistry kits. The contract has an ultimate completion date of September 30, 2023. Illumina is a key technology provider for federal scientific and diagnostic research initiatives, holding a $45 million Indefinite Delivery Contract with...
- This federal contract award is for the provision of ILLUMINA REAGENT CHEMISTRY KITS to the Food and Drug Administration (FDA), a civilian federal agency. The contract has a ceiling value of $102,963.12 and was awarded to the prime contractor Illumina, Inc., a for-profit manufacturer of genomic sequencing technologies. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is August 20, 2024. This award is not associated with a set-aside...